- Home
- NAMS vs GMS Comparison
NAMS vs GMS Comparison
Compare NAMS & GMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- GMS
- Stock Information
- Founded
- NAMS 2019
- GMS 1971
- Country
- NAMS Netherlands
- GMS United States
- Employees
- NAMS N/A
- GMS N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- GMS
- Sector
- NAMS Health Care
- GMS
- Exchange
- NAMS Nasdaq
- GMS Nasdaq
- Market Cap
- NAMS 2.5B
- GMS 2.9B
- IPO Year
- NAMS N/A
- GMS 2016
- Fundamental
- Price
- NAMS $21.54
- GMS $109.33
- Analyst Decision
- NAMS Strong Buy
- GMS Hold
- Analyst Count
- NAMS 8
- GMS 8
- Target Price
- NAMS $42.88
- GMS $105.71
- AVG Volume (30 Days)
- NAMS 976.0K
- GMS 2.3M
- Earning Date
- NAMS 08-06-2025
- GMS 08-28-2025
- Dividend Yield
- NAMS N/A
- GMS N/A
- EPS Growth
- NAMS N/A
- GMS N/A
- EPS
- NAMS N/A
- GMS 2.92
- Revenue
- NAMS $47,140,000.00
- GMS $5,513,738,000.00
- Revenue This Year
- NAMS N/A
- GMS $0.60
- Revenue Next Year
- NAMS N/A
- GMS $5.46
- P/E Ratio
- NAMS N/A
- GMS $37.46
- Revenue Growth
- NAMS 586.97
- GMS 0.21
- 52 Week Low
- NAMS $14.06
- GMS $65.77
- 52 Week High
- NAMS $27.29
- GMS $109.70
- Technical
- Relative Strength Index (RSI)
- NAMS 64.18
- GMS 79.28
- Support Level
- NAMS $17.97
- GMS $108.68
- Resistance Level
- NAMS $22.15
- GMS $109.48
- Average True Range (ATR)
- NAMS 0.92
- GMS 1.06
- MACD
- NAMS 0.35
- GMS 0.40
- Stochastic Oscillator
- NAMS 86.50
- GMS 97.01
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About GMS GMS Inc.
GMS Inc is a distributor of specialty building products including wallboard, suspended ceiling systems, ceilings, steel framing, and other complementary building products. The company serves its products to commercial new construction, commercial repair and remodel, residential new construction, and residential repair and remodel (R&R). Its geographical segment is Central, Midwest, New York, Northeast, Southern, Southeast, Southwest, Western and Canada. The company generates maximum revenue from Wallboard products.